Greater effectiveness in the treatment of arrhythmia with radio frequency energy and catheterization
(Universitat Pompeu Fabra - Barcelona) An article published in International Journal of Hyperthermia proposes a more effective protocol for the treatment of cardiac arrhythmias when applying radiofrequency energy at the site of the arrhythmia by catheterization. The research results from the final year project on the bachelor's degree in Biomedical Engineering by Sergi Coderch Navarro, supervised by Ana Gonz á lez Su á rez and Oscar Camara, researchers with the PhySense group of the BCN MedTech Research Unit. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 6, 2021 Category: International Medicine & Public Health Source Type: news
UBCO cardiovascular researcher urges women to listen to their hearts
(University of British Columbia Okanagan campus) Dr. Ryan Wilson, a post-doctoral fellow in the School of Nursing, says AF is the most commonly diagnosed arrhythmia (irregular heartbeat) in the world. Despite that, he says many people do not understand the pre-diagnosis symptoms and tend to ignore them. In fact, 77 per cent of the women in his most recent study had experienced symptoms for more than a year before receiving a diagnosis. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 5, 2021 Category: International Medicine & Public Health Source Type: news
Coffee Intake May Be Driven by Cardiovascular Symptoms Coffee Intake May Be Driven by Cardiovascular Symptoms
Observational results show those with hypertension, angina, or arrhythmia drink less coffee than those without. That behavior may explain mixed results in studies of coffee ' s effects.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 3, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
Scientists created technology to detect and treat complex arrhythmias
(Ural Federal University) Researchers have developed a breakthrough method for quickly, accurately, and reliably diagnosing cardiac arrhythmias. It coped with the task in 38 cases out of 51. In other words, it is highly effective in almost 75% of cases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news
Study: Pot users with arrhythmias face greater risk of death
Hospitalized marijuana users with irregular heartbeats are 4 1/2 times more likely to die than those with normal heart rates, research presented Friday during the Congress of the European Society of Cardiology showed. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 23, 2021 Category: Consumer Health News Source Type: news
Janssen Provides Update on Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Plus Prednisone Combination
RARITAN, N.J., April 19, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that regulatory submissions based on the Phase 3 ACIS study, which evaluated the combination of ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC), will not be pursued. As presented at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cancers Symposium in February 2021, the ACIS study met its primary endpoint of radiographic progression-free survival (rPFS); however, combination...
Source: Johnson and Johnson - April 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction
Amber Capone had become afraid of her husband. The “laid-back, bigger than life and cooler than cool” man she’d married had become isolated, disconnected and despondent during his 13 years as a U.S. Navy SEAL. Typically, he was gone 300 days of the year, but when he was home, Amber and their two children walked on eggshells around him. “Everyone was just playing nice until he left again,” Amber says.
In 2013, Marcus retired from the military. But life as a civilian only made his depression, anger, headaches, anxiety, alcoholism, impulsivity and violent dreams worse. Sometimes he’d get up...
Source: TIME: Health - April 5, 2021 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized Drugs feature Magazine Mental Health Source Type: news
Lamictal (lamotrigine): Drug Safety Communication - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease
FDA review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart disease who are taking the seizure and mental health medicine lamotrigine (Lamictal). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Ultrasound spots cardiac arrhythmic sites better than ECG
Ultrasound can more accurately map arrhythmic sites in the heart for improve...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation therapy can calm rapid heart rhythm
3D models advance therapy for heart rhythm disorders
SPECT, MRI together advance arrhythmia treatment
3D virtual heart helps pinpoint irregular heartbeat
CTA plus stress tests help predict heart attacks (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 19, 2021 Category: Radiology Source Type: news
Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by ove...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Massive suicidal ingestion of caffeine: a case report with investigation of the cardiovascular effect/concentration relationships - Gr émain V, Chevillard L, Saussereau E, Schnell G, Megarbane B.
BACKGROUND: Caffeine poisoning may cause life-threatening arrhythmias and hemodynamic failure. We aimed to investigate the toxicokinetics (TK), toxicodynamics (TD) and TK/TD relationships of caffeine in a case of poisoning. CASE REPORT: A 47-year-old male ... (Source: SafetyLit)
Source: SafetyLit - March 17, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
The Year in Cardiovascular Medicine 2020: Arrhythmias The Year in Cardiovascular Medicine 2020: Arrhythmias
This paper reviews new guidelines and important clinical trials and studies that were published in 2020 in the field of arrhythmias and pacing.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
What Are Generalized Anxiety Disorder Treatment Components?
Discussion
Generalized anxiety disorder (GAD) is “…excessive anxiety and worry about a number of events and activities coupled with at least one physical symptom, which may include fatigue, poor concentration, restlessness, irritability, muscle tension, and sleep difficulties.” Other ways it presents to the primary care office may be abdominal pain, headache or heart palpitations, dizziness, syncope, numbness, trembling, paresthesia, memory loss, or urinary frequency. It has an estimated prevalence of 15% and is the second most common anxiety disorder in children after social anxiety disorder. GAD can com...
Source: PediatricEducation.org - March 15, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
New-onset Arrhythmias Low in COVID-19 and Flu New-onset Arrhythmias Low in COVID-19 and Flu
New-onset atrial fibrillation or flutter is uncommon in patients hospitalized with COVID-19 and occurs at a rate similar to that seen in patients hospitalized with influenza.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 5, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
New open-source platform accelerates research into the treatment of heart arrhythmia's
(King's College London) An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering& Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterised by an irregular (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 26, 2021 Category: International Medicine & Public Health Source Type: news
